DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,194 filers reported holding DANAHER CORPORATION in Q4 2017. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $595,440 | +3.4% | 2,400 | 0.0% | 0.04% | +9.4% |
| Q2 2023 | $576,000 | +27.0% | 2,400 | +33.3% | 0.03% | +18.5% |
| Q1 2023 | $453,672 | +60959.5% | 1,800 | -35.7% | 0.03% | -34.1% |
| Q4 2022 | $743 | -99.9% | 2,800 | +7.7% | 0.04% | -2.4% |
| Q3 2022 | $672,000 | +4.8% | 2,600 | +2.8% | 0.04% | +7.7% |
| Q2 2022 | $641,000 | +209.7% | 2,530 | +301.6% | 0.04% | +254.5% |
| Q4 2021 | $207,000 | -68.9% | 630 | -71.2% | 0.01% | -70.3% |
| Q3 2021 | $666,000 | +0.5% | 2,187 | -11.5% | 0.04% | 0.0% |
| Q2 2021 | $663,000 | +19.2% | 2,472 | 0.0% | 0.04% | +15.6% |
| Q1 2021 | $556,000 | +20.9% | 2,472 | +19.3% | 0.03% | +14.3% |
| Q4 2020 | $460,000 | -92.4% | 2,072 | -95.1% | 0.03% | -93.7% |
| Q2 2019 | $6,075,000 | -8.2% | 42,505 | -15.2% | 0.44% | -11.3% |
| Q1 2019 | $6,615,000 | +43.3% | 50,105 | +11.9% | 0.50% | +30.4% |
| Q4 2018 | $4,616,000 | +4.3% | 44,760 | +9.9% | 0.38% | +19.1% |
| Q3 2018 | $4,427,000 | +2.1% | 40,740 | -7.3% | 0.32% | -3.6% |
| Q2 2018 | $4,336,000 | +4.9% | 43,940 | +4.1% | 0.33% | +6.1% |
| Q1 2018 | $4,132,000 | +13.7% | 42,205 | +7.8% | 0.31% | +17.2% |
| Q4 2017 | $3,634,000 | +2.9% | 39,155 | -4.9% | 0.27% | -1.8% |
| Q3 2017 | $3,530,000 | +23.6% | 41,155 | +21.6% | 0.27% | +22.5% |
| Q2 2017 | $2,857,000 | +15.3% | 33,855 | +16.8% | 0.22% | +9.9% |
| Q1 2017 | $2,478,000 | +3.9% | 28,975 | -5.4% | 0.20% | -0.5% |
| Q4 2016 | $2,384,000 | -3.5% | 30,625 | -2.9% | 0.20% | -3.8% |
| Q3 2016 | $2,471,000 | -52.3% | 31,525 | -38.6% | 0.21% | -49.9% |
| Q2 2016 | $5,184,000 | +6.3% | 51,325 | -0.2% | 0.42% | +1.0% |
| Q1 2016 | $4,878,000 | +4.6% | 51,425 | +2.4% | 0.42% | +2.7% |
| Q4 2015 | $4,665,000 | +38.2% | 50,225 | +26.8% | 0.41% | +31.8% |
| Q3 2015 | $3,376,000 | -0.7% | 39,625 | -0.3% | 0.31% | +10.0% |
| Q2 2015 | $3,400,000 | +8.0% | 39,725 | +7.1% | 0.28% | +14.8% |
| Q1 2015 | $3,148,000 | – | 37,075 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |